Lipid-lowering agents
- Lower atherogenic lipids and/or triglycerides
- Statins are ASCVD prevention foundation
- Ezetimibe/PCSK9 drugs add LDL lowering
- Fibrates/omega-3 target high triglycerides
- Outcome benefit differs by subclass
- Treat LDL risk—not just a lab number
Class at a glance
- Lower atherogenic lipids and/or triglycerides
Members / distinctions
- Statins are ASCVD prevention foundation
- Ezetimibe/PCSK9 drugs add LDL lowering
Other member distinctions
- Fibrates/omega-3 target high triglycerides
- Outcome benefit differs by subclass
Safety / monitoring
- Treat LDL risk—not just a lab number
Self-check
- Which lipid class is the ASCVD prevention foundation?
Statins. - Which lipid therapies target high triglycerides?
Fibrates/omega-3.
Drugs in this class (19)
Lipid-lowering agents prescription history
Animated chart of estimated U.S. prescriptions per year, Lipid-lowering meds (1955–2026).
All drug classes · Open Lipid-lowering agents in the interactive console ↗